Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -148.10 | 100.43 |
| PEG Ratio (TTM) | 2.05 | -1.21 |
| P/S Ratio (TTM) | 1.49 | 1.95 |
| P/B Ratio (TTM) | 0.61 | 2.01 |
| P/FCF Ratio (TTM) | 7.30 | 17.02 |
| Price to 5YR AVG Earnings Ratio | N/A | 18.74 |
| Price to 5YR AVG FCF Ratio | N/A | 15.58 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.25% | 2.96% |
| ROE (TTM) | -0.41% | 9.69% |
| Net Profit Margin (TTM) | -1.01% | 8.26% |
| ROIC 5YR AVG | 0.97% | 1.63% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -22.02% | -1,837.80% | -1,077.15% |
| Revenue | 1.30% | -4.62% | 7.24% |
| Net Income | 2.70% | -1,842.98% | -1,070.84% |
| Cash Flow | 44.51% | 40.35% | 55.30% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.83 | 2.27 |
| Quick Ratio (TTM) | 0.83 | 2.27 |
| D/E Ratio (TTM) | 0.55 | 1.23 |
| Interest Coverage (TTM) | 0.85 | 2.07 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | N/A | 1.44 |
| LTL to 5YR AVG FCF | 15.07 | 13.75 |
| Shares Outstanding Growth 5YR AVG | 1.18% | 2.92% |